# Sandu Pharmaceuticals Ltd (SANDUPHQ)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹38.39
Day Change: +3.23%
52W High: ₹58.8
52W Low: ₹30
Market Cap: ₹37 Cr

## Valuation
P/E: 18.19
P/B: 0.88
EPS: ₹2.11
Book Value: ₹43.5
Dividend Yield: 208%

## Returns
1Y Return: -25.47%

## Profitability
ROE: 10%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Sandu Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Sandu Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner, Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT, Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As Per Physical Verification Of Goods.
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner, Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT, Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As Per Physical Verification Of Goods.

## Data Freshness
Quote Updated: 2026-05-16T23:58:39.989Z
Price History Updated: 2026-05-19T01:02:44.275Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:02:44.275Z
Quant Updated: 2026-05-19T01:02:44.275Z
Sentiment Updated: 2026-05-19T01:02:44.275Z
Financials Status: current
Financials Updated: 2026-05-18T14:30:01.030Z
Financials Last Attempt: 2026-05-18T14:30:01.030Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2023)
Revenue: ₹65.5 Cr
Operating Profit: ₹2.88 Cr (OPM 4.4%)
Net Profit: ₹1.59 Cr
Tax: ₹2.32 Cr

## Annual P&L History
Mar 2023: Rev ₹65.5Cr | PAT ₹1.59Cr | OPM 4.4%
Mar 2024: Rev ₹65.35Cr | PAT ₹1.52Cr | OPM 3.79%
Mar 2025: Rev ₹67.28Cr | PAT ₹1.46Cr | OPM 3.42%

## Balance Sheet (Mar 2023)
Total Assets: ₹49.28 Cr
Total Liabilities: ₹49.28 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/sanduphq
Disclaimer: For research and education only. Not investment advice.